Literature DB >> 12030842

Variability in aflatoxin B(1)-macromolecular binding and relationship to biotransformation enzyme expression in human prenatal and adult liver.

Adriana M Doi1, Paula E Patterson, Evan P Gallagher.   

Abstract

Studies of transplacental transfer of aflatoxin B(1) (AFB(1)) suggest that the developing human fetus may be a sensitive target for AFB(1) injury. Because AFB(1) requires metabolic activation to the reactive AFB(1)-8,9-exo-epoxide (AFBO) to exert its carcinogenic effects, ontogenic and interindividual differences in AFB(1) biotransformation enzymes may underlie susceptibility to AFB(1)-induced cell injury. The present study was initiated to compare the rates of in vitro AFB(1)-DNA and AFB(1)-protein adduct formation among a panel of 10 adult and 10 second-trimester prenatal livers and to examine the relationship among AFB(1) metabolizing enzyme expression and AFB(1) binding. Mixtures of cytosolic and microsomal proteins from prenatal and adult livers catalyzed the formation of AFB(1)-DNA and AFB(1)-protein adducts at relatively similar rates, although greater individual variability in AFB(1) adduct formation was observed in adult tissues. Extensive interindividual variation among adult tissues was observed in the expression of the AFB(1) activation enzymes cytochrome P4501A2 (CYP1A2), CYP3A4/5, and lipoxygenase (LO). Prenatal CYP3A7 expression was also highly variable. LO expression was eightfold higher in prenatal liver tissues than adults, whereas the expression of the AFBO detoxification enzyme microsomal epoxide hydrolase was twofold higher in adult liver. The levels of the polymorphic glutathione S-transferase M1 (hGSTM1-1), which may potentially protect against AFBO injury, were higher in the hGSTM1-1-expressing tissues of adults in relation to prenatal livers. In general, there was not a strong relationship among AFB(1)-DNA or AFB(1)-protein adduct formation and expression levels of individual AFB(1) metabolizing enzymes. In summary, despite the presence of marked individual and ontogenic differences in the expression of AFB(1) metabolizing enzymes, human second trimester prenatal liver tissues compared to adults do not exhibit a marked sensitivity to the in vitro formation of macromolecular AFB(1) adducts. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030842     DOI: 10.1006/taap.2002.9399

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  8 in total

Review 1.  Aflatoxins: Implications on Health.

Authors:  Usha P Sarma; Preetida J Bhetaria; Prameela Devi; Anupam Varma
Journal:  Indian J Clin Biochem       Date:  2017-03-28

2.  Aflatoxin Exposure Among Mothers and Their Infants from the Western Highlands of Guatemala.

Authors:  Pauline E Jolly; Manolo Mazariegos; Haglaeeh Contreras; Nora Balas; Anna Junkins; Ibironke O Aina; Selina Minott; Meichen Wang; Timothy D Phillips
Journal:  Matern Child Health J       Date:  2021-05-04

Review 3.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

4.  In vitro recapitulating of TP53 mutagenesis in hepatocellular carcinoma associated with dietary aflatoxin B1 exposure.

Authors:  Ahmad Besaratinia; Sang-In Kim; Pierre Hainaut; Gerd P Pfeifer
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

5.  Curcumin Successfully Inhibited the Computationally Identified CYP2A6 Enzyme-Mediated Bioactivation of Aflatoxin B1 in Arbor Acres broiler.

Authors:  Ishfaq Muhammad; Xiaoqi Sun; He Wang; Wei Li; Xinghe Wang; Ping Cheng; Sihong Li; Xiuying Zhang; Sattar Hamid
Journal:  Front Pharmacol       Date:  2017-03-21       Impact factor: 5.810

Review 6.  Non‑infective occupational risk factors for hepatocellular carcinoma: A review (Review).

Authors:  Caterina Ledda; Carla Loreto; Christian Zammit; Andrea Marconi; Lucrezia Fago; Serena Matera; Valentina Costanzo; Giovanni Fuccio Sanzà; Stefano Palmucci; Margherita Ferrante; Chiara Costa; Concettina Fenga; Antonio Biondi; Cristoforo Pomara; Venerando Rapisarda
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

Review 7.  Aflatoxin Exposure During Pregnancy, Maternal Anemia, and Adverse Birth Outcomes.

Authors:  Laura E Smith; Andrew J Prendergast; Paul C Turner; Jean H Humphrey; Rebecca J Stoltzfus
Journal:  Am J Trop Med Hyg       Date:  2017-04       Impact factor: 2.345

8.  Maternal aflatoxin exposure during pregnancy and adverse birth outcomes in Uganda.

Authors:  Jacqueline M Lauer; Christopher P Duggan; Lynne M Ausman; Jeffrey K Griffiths; Patrick Webb; Jia-Sheng Wang; Kathy S Xue; Edgar Agaba; Nathan Nshakira; Shibani Ghosh
Journal:  Matern Child Nutr       Date:  2018-10-23       Impact factor: 3.092

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.